Report Detail

Medical Devices & Consumables Global Extracorporeal Life Support Devices Market Research Report 2021

  • RnM4261723
  • |
  • 01 April, 2021
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Venoarterial (VA) ECMO
Venovenous (VV) ECMO

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Medtronic
MAQUET Holding
Microport Scientific
Sorin Group
Nipro Medical
Terumo Cardiovascular Systems
MedosMedizintechnik
Getinge
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed


1 Extracorporeal Life Support Devices Market Overview

  • 1.1 Product Overview and Scope of Extracorporeal Life Support Devices
  • 1.2 Extracorporeal Life Support Devices Segment by Type
    • 1.2.1 Global Extracorporeal Life Support Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Venoarterial (VA) ECMO
    • 1.2.3 Venovenous (VV) ECMO
  • 1.3 Extracorporeal Life Support Devices Segment by Application
    • 1.3.1 Global Extracorporeal Life Support Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Global Extracorporeal Life Support Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Extracorporeal Life Support Devices Revenue 2016-2027
    • 1.4.2 Global Extracorporeal Life Support Devices Sales 2016-2027
    • 1.4.3 Extracorporeal Life Support Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Extracorporeal Life Support Devices Market Competition by Manufacturers

  • 2.1 Global Extracorporeal Life Support Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Extracorporeal Life Support Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Extracorporeal Life Support Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Extracorporeal Life Support Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Extracorporeal Life Support Devices Market Competitive Situation and Trends
    • 2.5.1 Extracorporeal Life Support Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Extracorporeal Life Support Devices Players Market Share by Revenue
    • 2.5.3 Global Extracorporeal Life Support Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Extracorporeal Life Support Devices Retrospective Market Scenario by Region

  • 3.1 Global Extracorporeal Life Support Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Extracorporeal Life Support Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Extracorporeal Life Support Devices Market Facts & Figures by Country
    • 3.3.1 North America Extracorporeal Life Support Devices Sales by Country
    • 3.3.2 North America Extracorporeal Life Support Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Extracorporeal Life Support Devices Market Facts & Figures by Country
    • 3.4.1 Europe Extracorporeal Life Support Devices Sales by Country
    • 3.4.2 Europe Extracorporeal Life Support Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Extracorporeal Life Support Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Extracorporeal Life Support Devices Sales by Region
    • 3.5.2 Asia Pacific Extracorporeal Life Support Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Extracorporeal Life Support Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Extracorporeal Life Support Devices Sales by Country
    • 3.6.2 Latin America Extracorporeal Life Support Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Extracorporeal Life Support Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Extracorporeal Life Support Devices Sales by Country
    • 3.7.2 Middle East and Africa Extracorporeal Life Support Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Extracorporeal Life Support Devices Historic Market Analysis by Type

  • 4.1 Global Extracorporeal Life Support Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Extracorporeal Life Support Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Extracorporeal Life Support Devices Price by Type (2016-2021)

5 Global Extracorporeal Life Support Devices Historic Market Analysis by Application

  • 5.1 Global Extracorporeal Life Support Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Extracorporeal Life Support Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Extracorporeal Life Support Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Medtronic
    • 6.1.1 Medtronic Corporation Information
    • 6.1.2 Medtronic Description and Business Overview
    • 6.1.3 Medtronic Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Medtronic Extracorporeal Life Support Devices Product Portfolio
    • 6.1.5 Medtronic Recent Developments/Updates
  • 6.2 MAQUET Holding
    • 6.2.1 MAQUET Holding Corporation Information
    • 6.2.2 MAQUET Holding Description and Business Overview
    • 6.2.3 MAQUET Holding Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 MAQUET Holding Extracorporeal Life Support Devices Product Portfolio
    • 6.2.5 MAQUET Holding Recent Developments/Updates
  • 6.3 Microport Scientific
    • 6.3.1 Microport Scientific Corporation Information
    • 6.3.2 Microport Scientific Description and Business Overview
    • 6.3.3 Microport Scientific Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Microport Scientific Extracorporeal Life Support Devices Product Portfolio
    • 6.3.5 Microport Scientific Recent Developments/Updates
  • 6.4 Sorin Group
    • 6.4.1 Sorin Group Corporation Information
    • 6.4.2 Sorin Group Description and Business Overview
    • 6.4.3 Sorin Group Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sorin Group Extracorporeal Life Support Devices Product Portfolio
    • 6.4.5 Sorin Group Recent Developments/Updates
  • 6.5 Nipro Medical
    • 6.5.1 Nipro Medical Corporation Information
    • 6.5.2 Nipro Medical Description and Business Overview
    • 6.5.3 Nipro Medical Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Nipro Medical Extracorporeal Life Support Devices Product Portfolio
    • 6.5.5 Nipro Medical Recent Developments/Updates
  • 6.6 Terumo Cardiovascular Systems
    • 6.6.1 Terumo Cardiovascular Systems Corporation Information
    • 6.6.2 Terumo Cardiovascular Systems Description and Business Overview
    • 6.6.3 Terumo Cardiovascular Systems Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Terumo Cardiovascular Systems Extracorporeal Life Support Devices Product Portfolio
    • 6.6.5 Terumo Cardiovascular Systems Recent Developments/Updates
  • 6.7 MedosMedizintechnik
    • 6.6.1 MedosMedizintechnik Corporation Information
    • 6.6.2 MedosMedizintechnik Description and Business Overview
    • 6.6.3 MedosMedizintechnik Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 MedosMedizintechnik Extracorporeal Life Support Devices Product Portfolio
    • 6.7.5 MedosMedizintechnik Recent Developments/Updates
  • 6.8 Getinge
    • 6.8.1 Getinge Corporation Information
    • 6.8.2 Getinge Description and Business Overview
    • 6.8.3 Getinge Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Getinge Extracorporeal Life Support Devices Product Portfolio
    • 6.8.5 Getinge Recent Developments/Updates
  • 6.9 BiVACOR
    • 6.9.1 BiVACOR Corporation Information
    • 6.9.2 BiVACOR Description and Business Overview
    • 6.9.3 BiVACOR Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 BiVACOR Extracorporeal Life Support Devices Product Portfolio
    • 6.9.5 BiVACOR Recent Developments/Updates
  • 6.10 SynCardia
    • 6.10.1 SynCardia Corporation Information
    • 6.10.2 SynCardia Description and Business Overview
    • 6.10.3 SynCardia Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 SynCardia Extracorporeal Life Support Devices Product Portfolio
    • 6.10.5 SynCardia Recent Developments/Updates
  • 6.11 Jarvik Heart
    • 6.11.1 Jarvik Heart Corporation Information
    • 6.11.2 Jarvik Heart Extracorporeal Life Support Devices Description and Business Overview
    • 6.11.3 Jarvik Heart Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Jarvik Heart Extracorporeal Life Support Devices Product Portfolio
    • 6.11.5 Jarvik Heart Recent Developments/Updates
  • 6.12 CARMAT
    • 6.12.1 CARMAT Corporation Information
    • 6.12.2 CARMAT Extracorporeal Life Support Devices Description and Business Overview
    • 6.12.3 CARMAT Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 CARMAT Extracorporeal Life Support Devices Product Portfolio
    • 6.12.5 CARMAT Recent Developments/Updates
  • 6.13 AbioMed
    • 6.13.1 AbioMed Corporation Information
    • 6.13.2 AbioMed Extracorporeal Life Support Devices Description and Business Overview
    • 6.13.3 AbioMed Extracorporeal Life Support Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 AbioMed Extracorporeal Life Support Devices Product Portfolio
    • 6.13.5 AbioMed Recent Developments/Updates

7 Extracorporeal Life Support Devices Manufacturing Cost Analysis

  • 7.1 Extracorporeal Life Support Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Extracorporeal Life Support Devices
  • 7.4 Extracorporeal Life Support Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Extracorporeal Life Support Devices Distributors List
  • 8.3 Extracorporeal Life Support Devices Customers

9 Extracorporeal Life Support Devices Market Dynamics

  • 9.1 Extracorporeal Life Support Devices Industry Trends
  • 9.2 Extracorporeal Life Support Devices Growth Drivers
  • 9.3 Extracorporeal Life Support Devices Market Challenges
  • 9.4 Extracorporeal Life Support Devices Market Restraints

10 Global Market Forecast

  • 10.1 Extracorporeal Life Support Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Extracorporeal Life Support Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Extracorporeal Life Support Devices by Type (2022-2027)
  • 10.2 Extracorporeal Life Support Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Extracorporeal Life Support Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Extracorporeal Life Support Devices by Application (2022-2027)
  • 10.3 Extracorporeal Life Support Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Extracorporeal Life Support Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Extracorporeal Life Support Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Extracorporeal Life Support Devices. Industry analysis & Market Report on Extracorporeal Life Support Devices is a syndicated market report, published as Global Extracorporeal Life Support Devices Market Research Report 2021. It is complete Research Study and Industry Analysis of Extracorporeal Life Support Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,250.40
    3,375.60
    4,500.80
    2,702.80
    4,054.20
    5,405.60
    447,441.00
    671,161.50
    894,882.00
    244,528.00
    366,792.00
    489,056.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report